| Lawrence Goldberg, MD | |
|
6950 Central Ave, St Petersburg, FL 33707-1210 | |
| (727) 343-3004 | |
| (727) 343-9521 |
| Full Name | Lawrence Goldberg |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 46 Years |
| Location | 6950 Central Ave, St Petersburg, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114931599 | NPI | - | NPPES |
| 066311500 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD0035408 (Florida) | Primary |
| Entity Name | Lawrence R Goldberg Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144530379 PECOS PAC ID: 5496949802 Enrollment ID: O20101029000904 |
News Archive
Approximately one in 20 patients with non-small cell lung carcinoma (NSCLC) has chromosomal aberrations targeting the anaplastic lymphoma kinase (ALK) gene. This has considerable implications for treatment because these patients are highly responsive to ALK-specific kinase inhibitors such as crizotinib.
Gamma Pharmaceuticals, Inc. announced the formation of a joint venture company with Jugular, Inc., replacing the brand licensing agreement in place between Gamma and Jugular since 2007. The new company, Gamma Jugular, LLC is closely integrated with Gamma's existing corporate infrastructure and distribution channels, and currently has three product lines and six SKUs with plans for expansion. Under the terms of the joint venture, Gamma will consolidate Gamma Jugular's performance into Gamma's financials.
Abbott Labs is splitting up. The diversified maker of medical products will become two companies: one focused on brand-name prescription drugs and the second on the other stuff, including medical devices, diagnostic tests and baby formula.
Abstral continues to grow strongly and is now also approved in the USA. OX-MPI has made significant progress towards clinical trials and has received its first milestone payment. The three new programs OX219, OX51 and OX27 announced in August 2010 have now all entered the clinical phase.
Eating Disorder Hope, a respected independent resource for individuals suffering from anorexia, bulimia, binge eating and other body image and eating disorders, has expanded its Eating Disorder Specialist Library to further help sufferers of anorexia, bulimia and binge eating disorder find treatment options.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lawrence Goldberg, MD 6250 Kipps Colony Ct Apt 304, Gulfport, FL 33707-3983 Ph: (727) 343-3004 | Lawrence Goldberg, MD 6950 Central Ave, St Petersburg, FL 33707-1210 Ph: (727) 343-3004 |
News Archive
Approximately one in 20 patients with non-small cell lung carcinoma (NSCLC) has chromosomal aberrations targeting the anaplastic lymphoma kinase (ALK) gene. This has considerable implications for treatment because these patients are highly responsive to ALK-specific kinase inhibitors such as crizotinib.
Gamma Pharmaceuticals, Inc. announced the formation of a joint venture company with Jugular, Inc., replacing the brand licensing agreement in place between Gamma and Jugular since 2007. The new company, Gamma Jugular, LLC is closely integrated with Gamma's existing corporate infrastructure and distribution channels, and currently has three product lines and six SKUs with plans for expansion. Under the terms of the joint venture, Gamma will consolidate Gamma Jugular's performance into Gamma's financials.
Abbott Labs is splitting up. The diversified maker of medical products will become two companies: one focused on brand-name prescription drugs and the second on the other stuff, including medical devices, diagnostic tests and baby formula.
Abstral continues to grow strongly and is now also approved in the USA. OX-MPI has made significant progress towards clinical trials and has received its first milestone payment. The three new programs OX219, OX51 and OX27 announced in August 2010 have now all entered the clinical phase.
Eating Disorder Hope, a respected independent resource for individuals suffering from anorexia, bulimia, binge eating and other body image and eating disorders, has expanded its Eating Disorder Specialist Library to further help sufferers of anorexia, bulimia and binge eating disorder find treatment options.
› Verified 7 days ago
Dr. Martin Edward Orlick, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5800 49th St N, S-109, St Petersburg, FL 33709 Phone: 727-522-1115 Fax: 727-522-0018 | |
David Earl Hall, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6950 Central Ave, St Petersburg, FL 33707 Phone: 727-343-3004 Fax: 727-345-0454 | |
Michael H Manning Jr., MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1515 9th Ave N, St Petersburg, FL 33705 Phone: 727-895-2020 Fax: 727-823-8796 | |
Dr. Orion Thomas Ayer, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1955 1st Ave N, St Petersburg, FL 33713 Phone: 727-894-3937 Fax: 727-821-0771 | |
David Aaron Eichenbaum, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4344 Central Ave, St Petersburg, FL 33711 Phone: 727-323-0077 Fax: 727-323-7627 | |
Thomas Griffin Bell, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 234 Beach Dr Ne, St Petersburg, FL 33701 Phone: 727-822-2001 Fax: 727-823-4549 |